[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
NKTR
NKTR surges on positive sentiment as Sanofi's atopic dermatitis trial disappoints, with internal documents from the NKTR vs. LLY lawsuit revealing potential misconduct.
About NKTR
Nektar Therapeutics ($NKTR) is a biopharmaceutical company focused on developing and commercializing innovative medicines.
Insights #
- nktr sentiment is up XXXXX% from the previous week.
Engagements: XXXXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXXX +1,207%
1 Year: XXXXXXXXXX +1,066%
1-Year High: XXXXXXXXX on 2025-06-24
1-Year Low: X on 2025-09-08
| Social Network | X | YouTube |
|---|---|---|
| Engagements | XXXXXXX | X |
Mentions: XXX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXXX +2,694%
1 Year: XXXXXX +2,561%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2025-09-08
| Social Network | X | YouTube |
|---|---|---|
| Mentions | XXX | X |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning NKTR in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XXX
1 Month: XX -XX%
6 Months: XXXXXX +2,721%
1 Year: XXXXXX +4,077%
1-Year High: XXXXX on 2025-06-25
1-Year Low: X on 2025-09-08
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +12%
1 Month: XX% -X%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-17
1-Year Low: XX% on 2025-03-31
Most Supportive Themes
- Positive Reaction to $SNY Data: (60%) The underperformance of Sanofi's ($SNY) amlitelimab in Phase X trials for atopic dermatitis has led to significant positive sentiment for Nektar Therapeutics ($NKTR), due to the potential of $NKTR's Rezpegaldesleukin.
- Strong Analyst Reactions: (20%) Analysts are highlighting the potential of $NKTR's Rezpegaldesleukin due to the underwhelming efficacy of $SNY's drug, further substantiating its competitive commercial potential.
Most Critical Themes
- Phase X Trial Risk: (10%) Some posts acknowledge the inherent risk that Phase X results may not translate into positive Phase X outcomes for $NKTR.
- Market Valuation Concerns: (10%) Some investors are concerned about the current valuation of $NKTR, considering the potential of the atopic dermatitis market and the data they already have.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXX | XX% | XXXXXX | XX% | XXXXXX | XX% |
| YouTube | X | X% | X | X% | X | X% |
| Total | XXXXXX | XX% | XXXXXX | XX% | XXXXXX | XX% |
Top assets mentioned In the posts about NKTR in the last XX hours
Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Incyte Corporation (INCY) Moderna Inc (MRNA) Regeneron Pharmaceuticals Inc (REGN) Sanofi (SNY) Synthetify (SNY) Merus N.V. Common Shares (MRUS) uniQure N.V. (QURE) Credo Technology Group Holding Ltd Ordinary Shares (CRDO)
Top topics mentioned In the posts about NKTR in the last XX hours
stocks healthcare, eli lilly, $lly, $incy, $mrna, regeneron pharmaceuticals inc, stocks technology, $abvx, sanofi, $sny, $mrus, $qure, $crdo, $ovid, $mlys, $pltr, $exel, stocks consumer cyclical, $ntla, $xbi, $abcl, $mstr, $apge, $crvs, stocks financial services, has been, coins solana ecosystem, acquisition, $1b, $mltx, $arwr, $cytk, $ptgx, $drug, coins defi, $psnl, $uber, coins meme, $idya, $pdli, market cap, $pali, $tecx, $insm, united therapeutics corp, $uthr, $rgnx, sarepta therapeutics inc, $evax, $dcth, $brns, $sprb, $guts, stocks industrials, stocks utilities, stocks basic materials, over the, advanced micro devices, $aapl, $cava, $ionq, $snys, $amgn, $cdtx, $mob, $nbis, $azn, the only, $sdot, $vktx, government shutdown, shutdown, money, $bbio, $sdgr, $galdsw, $amkr, dough, $lxeo, $zura, $meso, dopamine, $howl, $rna, $mdgl, $uly, $gctk, $qs, $jvsa, cuts, $arct, $tdoc, $hca, $uhs, $cyh, $srpt, $lqda, $ifrx, $regn, $aclx
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$NKTR FWIW chatgpt deep research is on the side of settlement and echoes what @seedy19tron said in his post. I prompted it to look if similar cases are vacated put on hold etc"
X Link @Duke0035 2025-10-15T11:06Z XXX followers, 2296 engagements
"$NKTR non-zero probability $LLY makes a bid for the company. Pay $1B they dont get anything from the deal. If they pay $2B now then 5B upon its a $20B potential what would you do if you were CEO I would option the company. Judge knows this and the market. #poker"
X Link @InfoBreakout 2025-10-15T05:17Z XXX followers, XXX engagements
"@buckorama1 I like this angle but can't they milk $LLY and $NKTR for a few more months now seems like free money maybe they can build a new pool house"
X Link @basadomente 2025-10-15T04:09Z XXX followers, XXX engagements
"They can raise capital on the P2 data the capital markets are wide open for them. But they raised only small amount of capital on that (excellent) P2 data. Obviously they calculated more to come from this lawsuit. It does not appear that will happen this month or next. Thus like I said it looks to me like $nktr will need to raise now in some way and that AA data is next event here"
X Link @bin2gray 2025-10-15T03:11Z XXX followers, XX engagements